Annual EBIT
-$67.52 M
-$32.00 M-90.11%
31 December 2023
Summary:
ARS Pharmaceuticals annual earnings before interest & taxes is currently -$67.52 million, with the most recent change of -$32.00 million (-90.11%) on 31 December 2023. During the last 3 years, it has fallen by -$48.07 million (-247.08%). SPRY annual EBIT is now -14296.59% below its all-time high of -$463.00 thousand.SPRY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$21.75 M
-$6.41 M-41.77%
30 September 2024
Summary:
ARS Pharmaceuticals quarterly earnings before interest & taxes is currently -$21.75 million, with the most recent change of -$6.41 million (-41.77%) on 30 September 2024. Over the past year, it has dropped by -$11.52 million (-112.67%). SPRY quarterly EBIT is now -242.81% below its all-time high of -$6.34 million, reached on 30 June 2022.SPRY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$60.51 M
-$3.77 M-6.64%
30 September 2024
Summary:
ARS Pharmaceuticals TTM earnings before interest & taxes is currently -$60.51 million, with the most recent change of -$3.77 million (-6.64%) on 30 September 2024. Over the past year, it has increased by +$7.01 million (+10.39%). SPRY TTM EBIT is now -752.32% below its all-time high of -$7.10 million, reached on 31 March 2022.SPRY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPRY EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -112.7% | +10.4% |
| 3 y3 years | -247.1% | - | - |
| 5 y5 years | - | - | - |
SPRY EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -247.1% | at low | -242.8% | at low | -752.3% | +16.8% |
| 5 y | 5 years | <-9999.0% | at low | -242.8% | at low | -752.3% | +16.8% |
| alltime | all time | <-9999.0% | at low | -242.8% | at low | -752.3% | +16.8% |
ARS Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.75 M(+41.8%) | -$60.51 M(+6.6%) |
| June 2024 | - | -$15.34 M(+16.3%) | -$56.74 M(-8.5%) |
| Mar 2024 | - | -$13.19 M(+29.0%) | -$62.00 M(-8.2%) |
| Dec 2023 | -$67.52 M | -$10.23 M(-43.1%) | -$67.52 M(-7.2%) |
| Sept 2023 | - | -$17.98 M(-12.7%) | -$72.74 M(+18.5%) |
| June 2023 | - | -$20.60 M(+10.1%) | -$61.39 M(+30.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$18.71 M(+21.2%) | -$47.13 M(+32.7%) |
| Dec 2022 | -$35.52 M(+82.6%) | -$15.44 M(+132.9%) | -$35.52 M(+76.9%) |
| Sept 2022 | - | -$6.63 M(+4.5%) | -$20.07 M(+49.3%) |
| June 2022 | - | -$6.34 M(-10.6%) | -$13.44 M(+89.4%) |
| Mar 2022 | - | -$7.10 M | -$7.10 M |
| Dec 2021 | -$19.45 M(+4048.0%) | - | - |
| Dec 2020 | -$469.00 K | - | - |
FAQ
- What is ARS Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly EBIT year-on-year change?
- What is ARS Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM EBIT year-on-year change?
What is ARS Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SPRY is -$67.52 M
What is the all time high annual EBIT for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual earnings before interest & taxes is -$463.00 K
What is ARS Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SPRY is -$21.75 M
What is the all time high quarterly EBIT for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$6.34 M
What is ARS Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SPRY quarterly earnings before interest & taxes has changed by -$11.52 M (-112.67%)
What is ARS Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SPRY is -$60.51 M
What is the all time high TTM EBIT for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM earnings before interest & taxes is -$7.10 M
What is ARS Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SPRY TTM earnings before interest & taxes has changed by +$7.01 M (+10.39%)